# Turkey's Domestic Heart-Lung Machine Completes Clinical Trials on 57 Patients

*Health · Health Desk · Published 2026-10-28T09:40:15Z*

Canonical: https://amk.news/article/turkey-s-domestic-heart-lung-machine-completes-clinical-trials-on-57-patients

> The Turkish-developed LIFELINE HLM heart-lung machine has successfully supported 57 open-heart surgery patients across three medical centers. This milestone marks a significant step in reducing national reliance on imported medical technology for critical cardiovascular procedures.

## Key points

- Turkish Health Minister Kemal Memişoğlu announced that a domestic heart-lung machine was successfully used in 57 clinical procedures across three separate hospitals on October 28, 2026.
- Ankara Bilkent City Hospital served as the initial clinical implementation site where the LIFELINE HLM heart-lung machine began its testing phase.
- Gaziantep University successfully utilized the domestic machine in four distinct procedures, including triple-vessel bypass and minimally invasive valve replacement.

On the morning of October 28, 2026, Turkish Health Minister Kemal Memişoğlu announced that a domestically developed heart-lung machine has been successfully utilized in 57 clinical procedures across three separate hospitals.[1](#dipnot-1) This development highlights Turkey's entry into a select group of only four nations worldwide capable of manufacturing this specialized life-support equipment.

## How does the LIFELINE HLM function during cardiac surgery?

The heart-lung machine acts as a critical bridge during open-heart surgery, assuming the functions of both the heart and lungs when the heart must be stopped to allow for surgical access. It removes blood from the body, oxygenates it, and returns it to circulation, effectively maintaining life during the most delicate stages of the operation.[2](#dipnot-2) Because the technical reliability of the device directly dictates patient safety, the expertise of the perfusionist team—who monitor blood flow, oxygen levels, and temperature in real-time—is as vital as the hardware itself.[4](#dipnot-4)

## What is the significance of the 57-patient data set?

The figure of 57 patients represents a multicenter achievement, verifying that the LIFELINE HLM performs consistently across different surgical environments and medical teams. Initial clinical implementation began at the Ankara Bilkent City Hospital, followed by further successful cases at Gaziantep University.[3](#dipnot-3) In one instance at the latter facility, the machine supported four distinct procedures, including triple-vessel bypass and minimally invasive valve replacement, demonstrating its versatility in clinical practice.

## What data is required to confirm the long-term success of the device?

While 57 patients provide a promising foundation, long-term validation of the LIFELINE HLM will require granular analysis beyond mere survival rates. Medical experts look for comprehensive data on postoperative recovery metrics, including duration in intensive care, rates of blood loss requiring transfusion, neurological complications, and 30-day mortality statistics.[4](#dipnot-4) For this technology to achieve widespread clinical trust, longitudinal reporting must detail how the device performs across high-risk patient profiles, such as pediatric cases or complex, long-duration surgeries.

## Notes and Sources

- Statement by Health Minister Kemal Memişoğlu, October 28, 2026. Reported by TRT Haber: [Domestic heart-lung machine successfully used in 57 patients](https://www.trthaber.com/haber/saglik/yerli-ve-milli-kalp-akciğer-makinesi-57-hastada-basariyla-kullanildi-961459.html). [↩](#ref-1)
- Melrose, D. G. (1953) early clinical framework of the heart-lung machine; for general operational principles, see: Cleveland Clinic, [Cardiopulmonary Bypass](https://my.clevelandclinic.org/health/treatments/24589-cardiopulmonary-bypass). [↩](#ref-2)
- Gaziantep University Press Office (August 26, 2026): [Surgeries with domestic heart-lung machine completed at GAÜN](https://habermerkezi.gaziantep.edu.tr/2026/08/26/yerli-kalp-akciger-makinesiyle-gaunde-yapilan-ameliyatlar-basariyla-tamamlandi/). [↩](#ref-3)
- Yanagawa, B. et al. (2020). Review of early-stage risk indicators associated with cardiopulmonary bypass: *Journal of Thoracic Disease*. DOI: [10.21037/jtd.2019.12.88](https://doi.org/10.21037/jtd.2019.12.88). [↩](#ref-4)

---
Source: AMK News (https://amk.news). Reuse requires attribution and a link to the canonical URL.